Sleep and comorbid neurologic disorders

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 1, 2013, Pages 148-169

  Watson, Nathaniel F ^a   Viola Saltzman, Mari ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; BENIGN CHILDHOOD EPILEPSY; BRAIN STEM; BREATHING; BREATHING DISORDER; CASE REPORT; CEREBROVASCULAR DISEASE; COMORBIDITY; DEMENTIA; DEMYELINATING DISEASE; DRUG EFFECT; EPILEPSY; FOREBRAIN; FRONTAL LOBE EPILEPSY; HEADACHE; HUMAN; HYPOTHALAMUS; HYPOVENTILATION; INSOMNIA; LEWY BODY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYOCLONUS EPILEPSY; NEUROLOGIC DISEASE; NOCICEPTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; QUALITY OF LIFE; REM SLEEP; REVIEW; RISK FACTOR; SLEEP; SLEEP DISORDER; SOMNOLENCE; SPINOCEREBELLAR DEGENERATION; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE;

ADULT; AGED; CEREBROVASCULAR DISORDERS; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RISK FACTORS; SLEEP DISORDERS;

EID: 84873689351     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000427208.13553.8c     Document Type: Review

References (91)

1. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001;163(1):19-25. (Pubitemid 32095247)
2. Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172(11):1447-1451. (Pubitemid 43069819)
3. Munoz R, Duran-Cantolla J, Martinez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006;37(9): 2317-2321. (Pubitemid 44337176)
4. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010;182(2):269-277.
5. Valham F, Mooe T, Rabben T, et al. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 2008;118(9):955-960.
6. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353(19):2034-2041. (Pubitemid 41609096)
7. Chami HA, Resnick HE, Quan SF, Gottlieb DJ. Association of incident cardiovascular disease with progression of sleep-disordered breathing. Circulation 2011;123(12):1280-1286.
8. Munoz R, Duran-Cantolla J, Martinez-Vila E, et al. Central sleep apnea is associated with increased risk of ischemic stroke in the elderly. Acta Neurol Scand 2012;126(3): 183-188.
9. Manfredini R, Boari B, Smolensky MH, et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int 2005; 22(3):417-453. (Pubitemid 41140869)
10. Casetta I, Granieri E, Fallica E, et al. Patient demographic and clinical features and circadian variation in onset of ischemic stroke. Arch Neurol 2002;59(1):48-53. (Pubitemid 34052555)
11. Hsieh SW, Lai CL, Liu CK, et al. Obstructive sleep apnea linked to wake-up strokes. J Neurol 2012;259(7):1433-1439.
12. Phillips RA, Sheinart KF, Godbold JH, et al. The association of blunted nocturnal blood pressure dip and stroke in a multiethnic population. Am J Hypertens 2000;13(12): 1250-1255.
13. Pringle E, Phillips C, Thijs L, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003;21(12):2251-2257. (Pubitemid 38293563)
14. Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens 2012;26(5): 281-287.
15. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19): 1378-1384. (Pubitemid 30262394)
16. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007;185(2):67-72. (Pubitemid 46571874)
17. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50(2):417-423. (Pubitemid 47205794)
18. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167(8):757-764.
19. Mo L, Gai J, He QY. The effect of chronic intermittent hypoxia caused by obstructive sleep apnea hypopnea syndrome on blood pressure [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi 2007;30(12):898-903.
20. Kohli P, Balachandran JS, Malhotra A. Obstructive sleep apnea and the risk for cardiovascular disease. Curr Atheroscler Rep 2011;13(2):138-146.
21. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107(20):2589-2594. (Pubitemid 36628941)
22. Lurie A. Endothelial dysfunction in adults with obstructive sleep apnea. Adv Cardiol 2011;46:139-170.
23. Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med 1994; 150(6 pt 1):1587-1591. (Pubitemid 24361731)
24. Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol 2008;105(6):1852-1857.
25. Oyama J, Yamamoto H, Maeda T, et al. Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 2012;35(4):231-236.
26. Lau EM, Yee BJ, Grunstein RR, Celermajer DS. Patent foramen ovale and obstructive sleep apnea: a new association? Sleep Med Rev 2010;14(6):391-395.
27. Pinet C, Orehek J. CPAP suppression of awake right-to-left shunting through patent foramen ovale in a patient with obstructive sleep apnoea. Thorax 2005;60(10):880-881. (Pubitemid 41475220)
28. Ciccone MM, Scicchitano P, Mitacchione G, et al. Is there a correlation between osas duration/severity and carotid intima-media thickness? Respir Med 2012;106(5):740-746.
29. Hui DS, Shang Q, Ko FW, et al. A prospective cohort study of the long-term effects of CPAP on carotid artery intima-media thickness in obstructive sleep apnea syndrome. Respir Res 2012;13:22.
30. Bulcun E, Ekici M, Ekici A. Disorders of glucose metabolism and insulin resistance in patients with obstructive sleep apnoea syndrome. Int J Clin Pract 2012;66(1):91-97.
31. Martinez-Garcia MA, Campos-Rodriguez F, Soler-Cataluna JJ, et al. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur Respir J 2012;39(4):906-912.
32. Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009;180(1):36-41.
33. Ryan CM, Bayley M, Green R, et al. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 2011; 42(4):1062-1067.
34. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000; 161(2 pt 1):375-380. (Pubitemid 30129441)
35. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999;22(2):217-223. (Pubitemid 29143220)
36. Magee CA, Kritharides L, Attia J, et al. Short and long sleep duration are associated with prevalent cardiovascular disease in Australian adults. J Sleep Res 2012;21(4): 441-447.
37. Watson NF. Stroke and sleep specialists: an opportunity to intervene? J Clin Sleep Med 2010;6(2):138-139.
38. Trotti LM, Esper CD, Feustel PJ, et al. Excessive daytime sleepiness in cervical dystonia. Parkinsonism Relat Disord 2009; 15(10):784-786.
39. Kuyper DJ, Parra V, Aerts S, et al. Nonmotor manifestations of dystonia: a systematic review. Mov Disord 2011;26(7):1206-1217.
40. Taylor N, Bramble D. Sleep disturbance and Huntingdon's disease. Br J Psychiatry 1997; 171:393.
41. Goodman AO, Barker RA. How vital is sleep in Huntington's disease? J Neurol 2010; 257(6):882-897.
42. Arnulf I, Nielsen J, Lohmann E, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 2008;65(4): 482-488. (Pubitemid 351549956)
43. Chandran V, Pal PK, Reddy JY, et al. Non-motor features in essential tremor. Acta Neurol Scand 2012;125(5):332-337.
44. Kostanecka-Endress T, Banaschewski T, Kinkelbur J, et al. Disturbed sleep in children with Tourette syndrome: a polysomnographic study. J Psychosom Res 2003;55(1):23-29. (Pubitemid 36949566)
45. Kirov R, Kinkelbur J, Banaschewski T, Rothenberger A. Sleep patterns in children with attention deficit hyperactivity disorder, tic disorder, and comorbidity. J Child Psychol Psychiatry 2007;48(6):561-570. (Pubitemid 46902326)
46. Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache 2006; 46(9):1344-1363. (Pubitemid 44556427)
47. Rains JC, Poceta JS. Sleep and headache disorders: clinical recommendations for headache management. Headache 2006; 46(suppl 3):S147-S148. (Pubitemid 44521787)
48. Spierings EL, van Hoof MJ. Fatigue and sleep in chronic headache sufferers: an age-and sex-controlled questionnaire study. Headache 1997;37(9):549-552. (Pubitemid 27508245)
49. Ohayon MM. Prevalence and risk factors of morning headaches in the general population. Arch Intern Med 2004;164(1):97-102. (Pubitemid 38067396)
50. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005;45(7):904-910. (Pubitemid 41045368)
51. Nobre ME, Leal AJ, Filho PM. Investigation into sleep disturbance of patients suffering from cluster headache. Cephalalgia 2005; 25(7):488-492. (Pubitemid 40896014)
52. Evers S. Sleep and headache: the biological basis. Headache 2010;50(7):1246-1251.
53. Buechler RD. Rodriguez AJ, Lahr BD, So EL. Ictal scalp EEG recording during sleep and wakefulness: diagnostic implications for seizure localization and lateralization. Epilepsia 2008;49(2):340-342. (Pubitemid 351171990)
54. Sinha S, Brady M, Scott CA, Walker MC. Do seizures in patients with refractory epilepsy vary between wakefulness and sleep? J Neurol Neurosurg Psychiatry 2006;77(9): 1076-1078. (Pubitemid 44338535)
55. Derry CP. The sleep manifestations of frontal lobe epilepsy. Curr Neurol Neurosci Rep 2011;11(2):218-226.
56. Eriksson SF. Epilepsy and sleep. Curr Opin Neurol 2011;24(2):171-176.
57. Sonka K, Juklickova M, Pretl M, et al. Seizures in sleep apnea patients: occurrence and time distribution. Sb Lek 2000;101(3): 229-232.
58. Malow BA, Levy K, Maturen K, Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 2000;55(7):1002-1007.
59. van Golde EG, Gutter T, de Weerd AW. Sleep disturbances in people with epilepsy; prevalence, impact and treatment. Sleep Med Rev 2011;15(6):357-368.
60. Parhizgar F, Nugent K, Raj R. Obstructive sleep apnea and respiratory complications associated with vagus nerve simulators. J Clin Sleep Med 2011;7(4):401-407.
61. Beran RG, Holland GJ, Yan KY. The use of CPAP in patients with refractory epilepsy. Seizure 1997;6(4):323-325. (Pubitemid 27399783)
62. Segal E, Vendrame M, Gregas M, et al. Effect of treatment of obstructive sleep apnea on seizure outcomes in children with epilepsy. Pediatr Neurol 2012;46(6):359-362.
63. Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2001;15(10):777-796. (Pubitemid 33065428)
64. Sukys-Claudino L, Moraes W, Guilleminault C, et al. Beneficial effect of donepezil on obstructive sleep apnea: a double-blind, placebo-controlled clinical trial. Sleep Med 2012;13(3):290-296.
65. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy. Brain 2007;130(pt 2):469-475. (Pubitemid 46181100)
66. Gaig C, Iranzo A. Sleep-disordered breathing in neurodegenerative diseases. Curr Neurol Neurosci Rep 2012;12(2):205-217.
67. Bonanni E, Maestri M, Tognoni G, et al. Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. J Sleep Res 2005;14(3):311-317. (Pubitemid 41291317)
68. Bhatt MH, Podder N, Chokroverty S. Sleep and neurodegenerative diseases. Semin Neurol 2005;25(1):39-51. (Pubitemid 40471625)
69. Comella CL. Sleep disturbances in parkinson's disease. Curr Neurol Neurosci Rep 2003;3(2):173-180. (Pubitemid 38898999)
70. Postuma RB, Gagnon JF, Vendette M, et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009;72(15):1296-1300.
71. Bliwise DL, Trotti LM, Yesavage JA, Rye DB. Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease. Eur J Neurol. 2012;19(6):918-923.
72. Benditt JO. Initiating noninvasive management of respiratory insufficiency in neuromuscular disease. Pediatrics 2009; 123(suppl 4):S236-S238.
73. Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000;161(1):166-170. (Pubitemid 30055920)
74. Bourke SC, Bullock RE, Williams TL, et al. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003;61(2):171-177. (Pubitemid 36875296)
75. Laberge L, Begin P, Dauvilliers Y, et al. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 2009;80(6):642-646.
76. Prudlo J, Koenig J, Ermert S, et al. Sleep disordered breathing in medically stable patients with myasthenia gravis. Eur J Neurol 2007;14(3):321-326. (Pubitemid 46384872)
77. Romigi A, Izzi F, Pisani V, et al. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 2011;18(9):1139-1145.
78. Lo Coco D, Piccoli F, La Bella V. Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord 2010;25(15): 2658-2661.
79. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler 2008;14(8):1127-1130.
80. Rammohan KW, Rosenberg JH, Lynn DJ, et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72(2):179-183.
81. Zifko UA, Rupp M, Schwarz S, et al. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 2002;249(8):983-987. (Pubitemid 35002216)
82. Heesen C, Nawrath L, Reich C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 2006;77(1):34-39. (Pubitemid 43022687)
83. Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler 2006; 12(4):481-486. (Pubitemid 44132589)
84. Kaynak H, Altintas A, Kaynak D, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol 2006;13(12):1333-1339. (Pubitemid 44736643)
85. Vetrugno R, Stecchi S, Scandellari C, et al. SleepVwake and body core temperature rhythms in multiple sclerosis with fatigue. Clin Neurophysiol 2007;118(1):228-234. (Pubitemid 44960944)
86. Manconi M, Fabbrini M, Bonanni E, et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 2007;14(5): 534-539. (Pubitemid 46587842)
87. Bensmail D, Marquer A, Roche N, et al. Pilot study assessing the impact of intrathecal baclofen administration mode on sleep-related respiratory parameters. Arch Phys Med Rehabil 2012;93(1):96-99.
88. Merlino G, Fratticci L, Lenchig C, et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 2009;10(1):26-34.
89. Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004;127(pt 2):1831-1844. (Pubitemid 39061559)
90. Glasauer FE, Egnatchick JE. Restless legs syndrome: an unusual cause for a perplexing syndrome. Spinal Cord 1999;37(12):862-865.
91. Lee MS, Choi YC, Lee SH, Lee SB. Sleep-related periodic leg movements associated with spinal cord lesions. Mov Disord 1996;11(6):719-722. (Pubitemid 26381944)